Uncategorized
Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Latest Ratings for AGIO Date Firm Action From To Mar 2022 Goldman Sachs Maintains Sell Mar 2022 HC Wainwright & Co. Maintains Buy Feb 2022 RBC Capital Maintains Outperform View More Analyst Ratings for AGIO View the Latest Analyst Ratings read more
What Analysts Are Saying About Viavi Solutions Stock
Latest Ratings for VIAV Date Firm Action From To Aug 2021 Morgan Stanley Maintains Equal-Weight Jul 2021 JP Morgan Downgrades Overweight Neutral Jul 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for VIAV View the Latest Analyst Ratings read more
Amazon Analysts See Growth Ahead With AWS In ‘Early Innings Of A Big AI Cycle,’ Advertising Segment Fast-Growing ‘Hidden Asset’
Amazon analysts raise price targets for the stock and center in on AWS growth and the AI opportunity with advertising called a future catalyst. Latest Ratings for AMZN Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Buy Feb 2022 Tigress Financial Maintains Buy Feb 2022 Credit Suisse Maintains Outperform View More…
Uber’s Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships
Uber’s Q3 results beat analyst expectations. JMP Securities sees opportunity for growth, raises target to $95. KeyBanc cautious on slower mobility growth. Latest Ratings for UBER Date Firm Action From To Mar 2022 Loop Capital Maintains Buy Mar 2022 Deutsche Bank Initiates Coverage On Buy Feb 2022 Wedbush Maintains Outperform View More Analyst Ratings for…